Skip to main content

Elevance Health to Hold Conference Call and Webcast to Discuss First Quarter Results on April 19, 2023

Elevance Health (NYSE: ELV) will release first quarter 2023 financial results on April 19, 2023, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers:

  • 888-947-9963 (Domestic)
  • 312-470-0178 (International)
  • 866-361-4942 (Domestic Replay)
  • 203-369-0190 (International Replay)

The access code for the call is 3972058. There is no access code for the replay. The replay will be available from 11:30 a.m. EDT on April 19, 2023 until the end of the day on May 19, 2023. The call will also be available through a live webcast at www.elevancehealth.com under the “Investors” link. A webcast replay will be available following the call.

About Elevance Health, Inc.

Elevance Health is a lifetime, trusted health partner fueled by its purpose to improve the health of humanity. The company supports consumers, families, and communities across the entire care journey – connecting them to the care, support, and resources they need to lead healthier lives. Elevance Health’s companies serve approximately 119 million people through a diverse portfolio of industry-leading medical, digital, pharmacy, behavioral, clinical, and complex care solutions. For more information, please visit www.elevancehealth.com or follow us @ElevanceHealth on Twitter and Elevance Health on LinkedIn.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  208.56
+3.29 (1.60%)
AAPL  272.14
+5.96 (2.24%)
AMD  213.84
+17.24 (8.77%)
BAC  50.41
-0.66 (-1.29%)
GOOG  310.92
-0.77 (-0.25%)
META  639.30
+2.05 (0.32%)
MSFT  389.00
+4.53 (1.18%)
NVDA  192.85
+1.30 (0.68%)
ORCL  146.14
+4.83 (3.42%)
TSLA  409.38
+9.55 (2.39%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.